









Markets
/
Stocks
/
nasdaq-ango
/

AngioDynamics Inc

ANGO

10.560USD

+0.500+4.97%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

439.02MMarket Cap

LossP/E TTM



AngioDynamics Inc

10.560

+0.500+4.97%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of AngioDynamics Inc

Currency: USD Updated: 2026-02-06

Key Insights

AngioDynamics Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 34 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 19.33.In the medium term, the stock price is expected to trend down.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

AngioDynamics Inc's Score

Industry at a Glance

Industry Ranking

34 / 205

Overall Ranking

122 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

AngioDynamics Inc Highlights

StrengthsRisks

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.

Undervalued

The company’s latest PE is -15.72, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 40.19M shares, decreasing 0.03% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 3.91K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.36.

Analyst Rating

Based on 4 analysts

Buy

Current Rating

19.333

Target Price

+92.18%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of AngioDynamics Inc is 7.32, ranking 92 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 79.43M, representing a year-over-year increase of 9.04%, while its net profit experienced a year-over-year increase of 40.86%.

Score

Industry at a Glance

Previous score

7.32

Change



Financials

7.49

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.39

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.20

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.34

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.18

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

AngioDynamics Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of AngioDynamics Inc is 7.26, ranking 102 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -15.72, which is -431.25% below the recent high of 52.08 and -41.19% above the recent low of -22.20.

Score

Industry at a Glance

Previous score

7.26

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 34/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of AngioDynamics Inc is 8.50, ranking 24 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 17.00, with a high of 24.00 and a low of 16.00.

Score

Industry at a Glance

Previous score

8.50

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 4 analysts

Buy

Current Rating

19.333

Target Price

+92.18%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

114

Total

Median

Average

Company name

Ratings

Analysts

AngioDynamics Inc

ANGO

Stryker Corp

SYK

Abbott Laboratories

ABT

Medtronic PLC

MDT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of AngioDynamics Inc is 7.35, ranking 38 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 11.20 and the support level at 9.82, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.77

Change

0.58

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.198

Neutral

RSI(14)

46.007

Neutral

STOCH(KDJ)(9,3,3)

59.692

Neutral

ATR(14)

0.394

High Vlolatility

CCI(14)

19.652

Neutral

Williams %R

29.310

Buy

TRIX(12,20)

-0.649

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

10.434

Buy

MA10

10.309

Buy

MA20

10.342

Buy

MA50

11.878

Sell

MA100

11.737

Sell

MA200

10.685

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of AngioDynamics Inc is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 106.71%, representing a quarter-over-quarter decrease of 2.15%. The largest institutional shareholder is Steven Cohen, holding a total of 2.56M shares, representing 6.21% of shares outstanding, with 171.46% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Divisadero Street Capital Management, LP

3.68M

+8.33%

BlackRock Institutional Trust Company, N.A.

2.90M

-2.06%

Systematic Financial Management, L.P.

2.57M

+2.41%

Point72 Asset Management, L.P.

Star Investors

2.56M

+31.29%

The Vanguard Group, Inc.

Star Investors

2.36M

-5.03%

Armistice Capital LLC

1.64M

+7.08%

Segall Bryant & Hamill, LLC

1.32M

-2.74%

Dimensional Fund Advisors, L.P.

1.16M

-1.44%

Clemmer James C

1.13M

+0.89%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of AngioDynamics Inc is 6.15, ranking 64 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.50. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. AngioDynamics Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.